TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese
- Status
- UNKNOWN
- Phase
- PHASE2
Circulating EV Long RNA Profiles in SCLC
- Status
- UNKNOWN
- Phase
- NA
Anlotinib Plus Penpulimab as Second-line Treatment for Patients With Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)
- Status
- COMPLETED
- Phase
- PHASE2
Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC
- Status
- COMPLETED
- Phase
- N/A
A Phase Ib / IIA Study of AL8326 in Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Malignant Thoracic Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of PD-1 Antibody and PARP Inhibitor in Extensive Stage Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- NA
Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- NA
Efficacy and Safety Study of a New Therapeutic Strategy in the Treatment of Extended-Disease Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety and Efficacy of XmAb18087 ± Pembrolizumab in Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2